IL1B and neoplasm: In WZB117-treated animals, we noted an increase in expression of IL1β and other pro-inflammatory cytokines despite the attenuation of tumor burden, suggesting that the induction of anti-tumor CTL and NK immunity was sufficient to overcome this apparent increase in macrophage inflammation.